Article tools
Author information
Published in Volume 78, Issue 1 (July,1986)
J. Clin. Invest. 78(1): 26-30 (1986). doi:10.1172/JCI112560.
Copyright © 1986, The American Society for Clinical Investigation.

Research Article

Transplantation of normal bone marrow into a pig with severe von Willebrand's disease.

E J Bowie, L A Solberg, Jr, D N Fass, C M Johnson, G J Knutson, M L Stewart and L J Zoecklein

Published July, 1986

Bone marrow from a normal male pig was transplanted into a related female pig with severe homozygous von Willebrand's disease (vWd). After engraftment the circulating leukocytes were of the male karyotype, and the platelets were strongly positive for von Willebrand factor (vWF) by indirect immunofluorescence. The average level of vWF was 1.96 U/dl and of ristocetin cofactor was 2.8 U/dl. The ear immersion bleeding time before transplantation was consistently more than 15 min and afterwards varied between 5 min and more than 15 min. Transfused vWF corrected the bleeding time at a level of 10 U/dl, which is lower than that required for a von Willebrand pig. We concluded that: the plasmatic compartment is only minimally replenished by the vWF from platelets and megakaryocytes; and the platelet vWF alone only partially corrects the abnormal tests of the hemostatic mechanism in severe vWd.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 26
icon of scanned page 27
icon of scanned page 28
icon of scanned page 29
icon of scanned page 30
This article Copyright © 1986, The American Society for Clinical Investigation.

Articles that cite
this article:

Endothelial function and its assessment
Dirk C Felmeden, Gregory YH Lip
Expert Opin Invest Drugs 14(11):1319. [CrossRef]

Altered thrombus formation in von Willebrand factor-deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa
I. Marx, O. D. Christophe, P. J. Lenting, A. Rupin, M.-O. Vallez, T. J. Verbeuren, C. V. Denis
112(3):603. [CrossRef]

A revised model of platelet aggregation
Suhasini Kulkarni, Sacha M. Dopheide, Cindy L. Yap, Catherine Ravanat, Monique Freund, Pierre Mangin, Kathryn A. Heel, Alison Street, Ian S. Harper, Francois Lanza
J Clin Invest 105(6):783. [CrossRef]

Role for platelet von willebrand factor in supporting platelet-vessel wall interactions in von willebrand disease
R. Castillo, G. Escolar, J. Monteagudo, A. Ordinas, M. Garrido, M. Moia, A. B. Federici, P. M. Mannucci
Am J Hematol 31(3):153. [CrossRef]

von Willebrand Factor Biosynthesis and Processing
TANYA N. Mayadas, DENISA D. Wagner
Ann N Y Acad Sci 614(1 process in va):153. [CrossRef]

Alpha granule proteins in type I von Willebrand's disease
Laurie P. Mckeown, Sybil B. Williams, Brenda Shafer, Natalie Murray, Harvey R. Gralnick
Am J Hematol 42(2):158. [CrossRef]

Absence of incorporation of plasma von Willebrand factor into porcine platelet a-granules
JACQUELINE Roussi, LUDOVIC Drouet, JEFF Sigman, MARCEL Vaiman, GEORGES Pignaud, MICHEL Bonneau, JEAN-MARC Masse, ELISABETH MARTIN Cramer
Br J Haematol 90(3):661. [CrossRef]

An in vitro model for the study of acute release of von Willebrand factor from human endothelial cells
F. Booth, M. J. Allington, S. A. Cederholm-williams
Br J Haematol 67(1):71. [CrossRef]

Differences and similarities in tyrosine phosphorylation of proteins in platelets from human and pig species
M. J. Zurbano, B. Fuste, G. Arderiu, G. Escolar, A. Ordinas, M. Diaz-ricart
J Thromb Haemost 1(11):2411. [CrossRef]

Studies of multimerin in patients with von Willebrand disease and platelet von Willebrand factor deficiency
Christine I. Chen, Augusto B. Federici, Elisabeth M. Cramer, Maria T. Canciani, Paul Harrison, Shilun Zheng, Jean-Marc Masse, Pier M. Mannucci, Catherine P. M. Hayward
Br J Haematol 103(1):20. [CrossRef]

Von Willebrand factor, platelets and endothelial cell interactions
Z. M. Ruggeri
J Thromb Haemost 1(7):1335. [CrossRef]


Zaverio Ruggeri
Curr Opin Hematol 10(2):142. [CrossRef]

Clinical significance of von Willebrand factor in patients with adult dermatomyositis
Toshiyuki Komiya, Nobuo Negoro, Kyoko Kondo, Katsuyuki Miura, Yoshio Hirota, Junichi Yoshikawa
Clin Rheumatol 24(4):352. [CrossRef]

Elevation of serum von Willebrand factor and anti-endothelial cell antibodies in patients with immunoglobulin A nephropathy are associated with intrarenal arterial lesions
JUN-JUN Zhang, LEI Jiang, GANG Liu, SU-XIA Wang, WAN-ZHONG Zou, HONG Zhang, MING-HUI Zhao
Nephrology (Carlton) 13(8):712. [CrossRef]

The Effect of Vasopressin and Related Compounds at V1a and V2 Receptors in Animal Models Relevant to Human Disease*
Mads Bjelke Petersen
Bas Clin Pharmacol Toxicol 99(2):96. [CrossRef]

Cells and Aggregates at Surfaces
VINCENT T. Turitto, HARVEY J. Weiss, HANS R. Baumgartner, LINA Badimon, VALENTIN Fuster
Ann N Y Acad Sci 516(1 blood in cont):453. [CrossRef]

Studies on the platelet surface-associated von Willebrand factor
S. Eric Martin, Margaret M. Johnson, Robert F. Abel
Am J Hematol 46(1):1. [CrossRef]

von Willebrand Factor and Platelet Function
HARVEY J. Weiss
Ann N Y Acad Sci 614(1 process in va):125. [CrossRef]

The Fine Structure of von Willebrand Factor Multimers and Type IIA von Willebrand Disease
Dennis C. Lynch
Ann N Y Acad Sci 614(1 process in va):138. [CrossRef]

Relationship of thrombohemorrhagic complications to endothelial cell function in patients with chronic myeloproliferative disorders
W. R. Friedenberg, R. C. Roberts, D. E. David
Am J Hematol 40(4):283. [CrossRef]